ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Featured News

  • 05 Feb 2014 10:00 AM | Christopher McCoy
    Each January, CLSI updates standards for antimicrobial susceptibility testing (AST). It is important for clinical laboratories to incorporate the new recommendations into routine practice to optimize detection and reporting of antimicrobial resistance. As of January 2014, the annual update of the M100 tables (CLSI document M100-S24) has been published. Some highlights for 2014 include guidelines for testing cefazolin as a surrogate for oral agents that might be used for treating uncomplicated urinary tract infections and interpreting results for carbapenems and Acinetobacter spp. The revised breakpoints for cefepime and Enterobacteriaceae, including the new susceptible-dose dependent interpretive category will be explained. These changes and several other new recommendations found in M100-S24 will be discussed. In addition to the webinar, an optional post-program self-assessment will be held that will allow individuals to assess their knowledge regarding the most important AST and reporting issues for 2014.  To learn more and register visit here.
  • 28 Jan 2014 8:18 AM | Christopher McCoy
    Visit our ID WebLinks page for some new resources including information on Superbugs and antimicrobial resistance, the Center for Disease, Dynamics Economics and Policy and a variety of resources for HIV/AIDs care.
  • 28 Jan 2014 8:02 AM | Christopher McCoy
    Advisory Committee on Immunization Practices (ACIP) updates the guidelines each year. The newest guidance may be found at the CDC website.
  • 13 Jan 2014 4:58 PM | Christopher McCoy
    We would like to follow our members.  Please email us at to send us your name on Twitter.  Follow us at SIDPharm, visit SIDP Twitter site
  • 06 Dec 2013 4:03 PM | Christopher McCoy
    Sovaldi is one of the more anticipated oral agents available to treat certain types of HCV infection, in some cases without the need for co-administration of interferon.  Unlike other recently available agents which have failed to meet the anticipated benefit, the drug may be combined with an all oral regimen and early signs indicate a low pill burden with lesser adverse effects. 
  • 05 Dec 2013 8:19 PM | Christopher McCoy
    You still have time, see our event listings for details.  With all the new vaccines available, document your clinical experience. Also, just released today are the IDSA guidelines for vaccination of immunocompromised patients.
  • 20 Nov 2013 4:11 PM | Christopher McCoy
    As in past years, the effort coordinates the work of CDC’s Get Smart: Know When Antibiotics Work campaign, state-based appropriate antibiotic use campaigns, non-profit partners, and for-profit partners during a one week observance of antibiotic resistance and the importance of appropriate antibiotic use. Its geared across healthcare settings so whether you practice in an ambulatory setting or a large teaching institution, there is something for you to engage in.  Some of you may have sat in on the live teleconference on Tuesday.  Others may want to particpate in the program on Friday on Twitter.
    • Friday, November 22, 2013 at 1 p.m. EST
      Twitter Chat with @CDCgov on antibiotic resistance and appropriate antibiotic use
      ParticipateExternal Web Site Icon with hashtag #SaveAbx

    Find info on the website to share with patients, for continuing education needs, for flyers related to stewardship activities. 

  • 20 Nov 2013 4:07 PM | Christopher McCoy

    New toolkit aims to decrease central line-associated bloodstream infections (CLABSI)

    A new toolkit, "Preventing Central Line-Associated Bloodstream Infections – Useful Tools, An International Perspective," developed by The Joint Commission, Joint Commission Resources and Joint Commission International is now available to help healthcare organizations implement practices to reduce these preventable infections that threaten lives and increase healthcare costs. The toolkit is a companion piece to a 2012 monograph with the same title, but subtitled, "A Global Challenge, A Global Perspective." The resources cover central lines only and are designed for healthcare personnel who insert and care for intravascular catheters and who are responsible for the surveillance, prevention and control of infections in all healthcare settings. For more information, go to the website.

  • 23 Sep 2013 5:23 PM | Christopher McCoy

    The four episode series, you can choose how many you want, addresses clinical effectiveness of the vaccine, new vaccine formulations including the quadrivalent vaccine and proposed ACIP changes.  Each is good for 0.5 ACPE CEU.  For details and a link, visit our Educational Resources page.

    Clinical Update for the 2013-2014 Flu Season  - Expert Interview Digest

  • 23 Sep 2013 5:17 PM | Christopher McCoy
    A reported record number of attendees were present at the annual meeting in Denver.  Full details of the half day meeting of lectures, awards and the reception will be forthcoming.  The new board was installed with Joseph Kuti of Hartford Hospital and the Center for Antiinfective Research and Development taking the role as incoming President.  For a full review of the board roster visit the About Us tab.  Don't forget to sign up for committees in the meantime.

Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events


Society of Infectious Diseases Pharmacists • 403 W. Saint Charles, Suite B, Lombard, IL 60148
(331) 248-7888
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software